These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19666083)

  • 21. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
    Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
    Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cannabinoid receptor agonists on streptozotocin-induced hyperalgesia in diabetic neuropathy.
    Bujalska M
    Pharmacology; 2008; 82(3):193-200. PubMed ID: 18810243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
    Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
    Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.
    Pamplona FA; Prediger RD; Pandolfo P; Takahashi RN
    Psychopharmacology (Berl); 2006 Nov; 188(4):641-9. PubMed ID: 16947018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes.
    Nieri P; Greco R; Adinolfi B; Breschi MC; Martinotti E; Nannetti C; Podestà A
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):352-9. PubMed ID: 14566452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
    Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
    Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid exposure in pubertal rats increases spontaneous ethanol consumption and NMDA receptor associated protein levels.
    Klugmann M; Klippenstein V; Leweke FM; Spanagel R; Schneider M
    Int J Neuropsychopharmacol; 2011 May; 14(4):505-17. PubMed ID: 21211107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex differences in cannabinoid receptor-1 (CB1) pharmacology in mice selectively bred for high voluntary wheel-running behavior.
    Keeney BK; Meek TH; Middleton KM; Holness LF; Garland T
    Pharmacol Biochem Behav; 2012 Jun; 101(4):528-37. PubMed ID: 22405775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine.
    Leweke FM; Schneider M
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):43-51. PubMed ID: 20678304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats.
    Spano MS; Fadda P; Frau R; Fattore L; Fratta W
    Eur Neuropsychopharmacol; 2010 Jan; 20(1):25-36. PubMed ID: 19854030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prenatal exposure to the CB-1 receptor agonist WIN 55212-2 or CO on the GABAergic neuronal systems of rat cerebellar cortex.
    Benagiano V; Lorusso L; Flace P; Girolamo F; Rizzi A; Sabatini R; Auteri P; Bosco L; Cagiano R; Ambrosi G
    Neuroscience; 2007 Nov; 149(3):592-601. PubMed ID: 17916407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CB1 Ligands on Neurogenic and Myogenic Contractile Responses in the Guinea-Pig Ileum.
    Donnerer J; Liebmann I
    Pharmacology; 2018; 101(5-6):330-336. PubMed ID: 29627825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
    Fattore L; Cossu G; Martellotta CM; Fratta W
    Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors.
    Abalo R; Cabezos PA; Vera G; López-Miranda V; Herradón E; Martín-Fontelles MI
    Neurogastroenterol Motil; 2011 May; 23(5):457-67, e177. PubMed ID: 21303434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoid self-administration in rats: sex differences and the influence of ovarian function.
    Fattore L; Spano MS; Altea S; Angius F; Fadda P; Fratta W
    Br J Pharmacol; 2007 Nov; 152(5):795-804. PubMed ID: 17891164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood.
    Alteba S; Korem N; Akirav I
    Learn Mem; 2016 Jul; 23(7):349-58. PubMed ID: 27317195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decision making.
    Schulz S; Becker T; Nagel U; von Ameln-Mayerhofer A; Koch M
    Pharmacol Biochem Behav; 2013 May; 106():91-100. PubMed ID: 23541493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats.
    Chi OZ; Barsoum S; Grayson J; Hunter C; Liu X; Weiss HR
    Pharmacology; 2012; 89(5-6):333-8. PubMed ID: 22678129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.